Theranostics is the combination of two approaches—diagnostics and therapeutics—applied
for decades in cancer imaging using radiopharmaceuticals or paired radiopharmaceuticals …

Imaging and tracking biological targets or processes play an important role in revealing
molecular mechanisms and disease states. Bioimaging via optical, nuclear, or magnetic …

Acute thrombosis and thromboembolisms are one of the leading causes of mortality and
morbidity in both developed and developing countries, placing a huge burden on health and …

The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more
than 95% of cases. A suitable choice for the treatment of DTC is the systemic administration …

Purpose Radioactive iodine (131I) therapy is a conventional post-surgery treatment widely
used for papillary thyroid carcinoma (PTC). Since 131I is orally administered, we …

Thyroid cancer (TC) is the most frequent malignancy of the endocrine system. Apatinib, as
an anti-angiogenic agent, has been applied in the therapy of several cancers. However, the …

Thyroid cancers require complex and heterogeneous therapies with different impacts on
renal function. In our systematic literature review, we analyzed several aspects: renal …

Background Despite the potential radiotoxicity in differentiated thyroid cancer (DTC) patients
with high-dose 131I therapy, the alterations and regulatory mechanisms dependent on …

Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …

Radioresistance is a crucial factor for the failure of iodine 131 (131I)-based radiotherapy for
differentiated thyroid carcinoma (DTC). This study aimed to explore the effect of circ_NEK6 …